Using NK cells to treat cancer

Jeffrey S. Miller, MD, University of Minnesota, Minneapolis, MN, discusses how natural killer (NK) cell products can be used to treat cancer. Specifically highlighted are the reductions in graft-versus-host disease (GvHD), cytokine release syndrome (CRS), and neurotoxicity expected with NK-cell therapy. This interview took place during the 36th Society for Immunotherapy of Cancer (SITC) Annual Meeting in Washington, D.C.